The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update Issue 10 (PDF).
This issue includes the following drug safety advice articles:
- Rimonabant (Acomplia): depression; psychiatric adverse reactions
- Exenatide (Byetta): risk of acute pancreatitis
In addition, this issue contains a hot topic containing information about monitoring the safety of antiretroviral drugs. There is also a pointer to the Drug Analysis Print (DAP) area of the MHRA website. These DAP documents contain detailed listings of suspected adverse drug reactions reported to the MHRA through the Yellow Card scheme. Finally, there is a stop press section highlighting important safety issues that have arisen in the last month.
Action: Clinicians will find this publication to be a useful review of current issues in drug safety.
|« Bisphosphonates linked to AF||Management of Asthma guideline updated »|